CIK 0001514183 · Non-accelerated filer<br>Smaller reporting company
Silo Pharma, Inc.
Sign in to watch- Ticker
- SILO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 462137136
- Phone
- (718) 400-9031
- Business address
- 677 N. WASHINGTON BLVD, SARASOTA, FL, 34236
- Former names
- Uppercut Brands, Inc., Point Capital, Inc., Gold Swap Inc
- UPLOAD Other SEC-generated Letter
- 4 Open-market buy Chief Executive Officer bought 22,500 shares at an average $0.14 ($3,187)
- S-1 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Material agreement
- 8-K Event Material agreement
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Other events
- 8-K Event Material agreement
- 10-Q Report Quarterly Report
- 10-K/A Report 10-K/A
- 4/A Grant or award CEO, CFO and President acquired 7,630,949 shares (grant or award)
- 4 Open-market buy CEO, CFO and President bought 58,114 shares at an average $0.00 ($281)
- 8-K Event Material agreement · Other events
- 8-K Event Material agreement · Unregistered share sale
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
Page 11 of 19 · 380 filings